Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label Olaparib. Show all posts
Showing posts with label Olaparib. Show all posts
Tuesday, February 13, 2018

FDA grants approval for first drug to treat inherited breast cancer

›
In continuation of my update on olaparib The U.S. Food and Drug Administration  expanded the approved use of Lynparza (olaparib tabl...
Wednesday, March 11, 2015

FDA approves Myriad’s BRACAnalysis CDx for use with ovarian cancer drug

›
In continuation of my update on Olaparib Myriad Genetics, Inc.    announced that it has received approval from the U.S. Food and Drug ...
Saturday, March 31, 2012

Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer — NEJM

›
We know that Olaparib ,  is a experimental  chemotherapeutic agent ,  developed  by  KuDOS Pharmaceuticals  and later by  Astra Zeneca , t...
1 comment:
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.